Opti India Pharma Private Limited
About Opti India Pharma Private Limited
Data last updated:
Opti India Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 30 July 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24299MH2021PTC364984.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Karan Sabnani and Kavita Sabnani.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 208 2nd Floor Kamala Bhavan Sharma Indl Estate Walbhat Road Goregaon East, Mumbai, Maharashtra, India – 400063.
As per the financials filed for FY 2025, the company reported a revenue of ₹21.81 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹32,392 (net margin 1.5%) and EBITDA of ₹39,260 (EBITDA margin 1.8%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address208 2nd Floor Kamala Bhavan Sharma Indl Estate Walbhat Road Goregaon East, Mumbai, Maharashtra, India – 400063
- IndustryChemicals, Manufacturing, Other Chemical Product, Fine Chemicals And Other Chemical Products
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Opti India Pharma Private Limited
The main business activity of Opti India Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Opti India Pharma Private Limited FY 2025 filings available
Opti India Pharma Private Limited reported revenue of ₹21.81 Lakh (up 432% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Opti India Pharma Private Limited
Revenue rose 432% in the latest year. EBITDA rose 100% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Opti India Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹39,260 | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹32,392 | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Opti India Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.8% | •••• | •••• | •••• |
| Net Profit Margin | 1.5% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Opti India Pharma are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Opti India Pharma Private Limited
Opti India Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shree Hemal Organics Private Limited | ₹21.86 Lakh (FY 2024) | •••• | •••• | -13.0% | •••• | Silvassa, Dadra and Nagar Haveli, India |
| Cementolime Sustainable Coatings Private Limited | ₹21.86 Lakh (FY 2025) | •••• | •••• | •••• | Ratan Lal Nagar, Uttar Pradesh, India | |
| Dazzling Plaster Private Limited | ₹21.85 Lakh (FY 2017) | •••• | •••• | -5.0% | •••• | Gwalior, Madhya Pradesh, India |
| Shravin Labs Private Limited | ₹21.85 Lakh (FY 2020) | •••• | •••• | -21.0% | •••• | Mumbai, Maharashtra, India |
| Astrel Genome Limited | ₹21.82 Lakh (FY 2025) | •••• | •••• | 792.0% | •••• | Patancheru, Telangana, India |
| Opti India Pharma Private Limited this company | ₹21.81 Lakh (FY 2025) | •••• | •••• | 432.0% | •••• | Mumbai, Maharashtra, India |
| Herbs Era Pharmaceuticals Pvt Ltd | ₹21.81 Lakh (FY 2025) | •••• | •••• | -28.0% | •••• | Madhyamgram, West Bengal, India |
| Amnium Technologies Private Limited | ₹21.79 Lakh (FY 2023) | •••• | •••• | 23.0% | •••• | Pune, Maharashtra, India |
| Parsit Agarbatti Works Private Limited | ₹21.73 Lakh (FY 2016) | •••• | •••• | -26.0% | •••• | Ahmedabad, Gujarat, India |
| Nirma Industries Private Limited | ₹21.73 Lakh (FY 2024) | •••• | •••• | -94.0% | •••• | Ahmedabad, Gujarat, India |
| Schelling Pharma Private Limited | ₹21.72 Lakh (FY 2023) | •••• | •••• | -39.0% | •••• | Jaipur, Rajasthan, India |
Peers are the five companies nearest above and the five nearest below Opti India Pharma by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Opti India Pharma Private Limited
Opti India Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Karan Sabnani | Director | 30 Jul 2021 | 5 Years 2 Months | Current |
| Kavita Sabnani | Additional Director | 30 Jun 2025 | 1 Years 3 Months | Current |
Charges & Borrowings of Opti India Pharma Private Limited
Opti India Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Opti India Pharma Private Limited
Employment history and EPFO contributions of people linked to Opti India Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Opti India Pharma Private Limited
Opti India Pharma Private Limited has 3 board changes on record since 2021: 2 appointments and 1 cessation. The latest: Sunil Sabnani ceased to be Director on 02 Sep 2025.
Credit Ratings, Litigation & Regulatory Alerts for Opti India Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Opti India Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Opti India Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Opti India Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Opti India Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Opti India Pharma Private Limited
Opti India Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 30 July 2021 (5+ years old) and is registered under CIN U24299MH2021PTC364984.
Opti India Pharma reported revenue of ₹21.81 Lakh for FY 2025 (up 432% YoY).
Opti India Pharma has 2 current directors:
- Karan Sabnani - Director
- Kavita Sabnani - Additional Director
Opti India Pharma reported a net profit of ₹32,392 (net margin 1.5%) and EBITDA of ₹39,260 (EBITDA margin 1.8%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Opti India Pharma is U24299MH2021PTC364984. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Opti India Pharma was incorporated on 30 July 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Opti India Pharma by revenue are Shree Hemal Organics Private Limited, Cementolime Sustainable Coatings Private Limited, Dazzling Plaster Private Limited, Shravin Labs Private Limited, Astrel Genome Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sunil Sabnani ceased to be Director on 02 Sep 2025. Kavita Sabnani was appointed as Additional Director on 30 Jun 2025. Karan Sabnani was appointed as Director on 30 Jul 2021.
The registered office of Opti India Pharma is at 208 2nd Floor Kamala Bhavan Sharma Indl Estate Walbhat Road Goregaon East, Mumbai, Maharashtra, India – 400063.
Opti India Pharma has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
Opti India Pharma operates in the chemicals industry, in the manufacturing segment.